A New Perspective for Osteosarcoma Therapy: Proteasome Inhibition by MLN9708/2238 Successfully Induces Apoptosis and Cell Cycle Arrest and Attenuates the Invasion Ability of Osteosarcoma Cells in Vitro
Background: The proteasome exists in all eukaryotic cells and provides the main route of intracellular proteins degradation involved in cell growth and apoptosis. Proteasome inhibition could block protein degradation pathways and disturb regulatory networks, possibly leading to profound effects on c...
Main Authors: | Renhao Liu, Chunjiang Fu, Jiabing Sun, Xvming Wang, Shuo Geng, Xiaoyu Wang, Jilong Zou, Zhenggang Bi, Chenglin Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Cell Physiol Biochem Press GmbH & Co KG
2017-01-01
|
Series: | Cellular Physiology and Biochemistry |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/456598 |
Similar Items
-
Renal medullary carcinomas depend upon SMARCB1 loss and are sensitive to proteasome inhibition
by: Andrew L Hong, et al.
Published: (2019-03-01) -
Dynamics of tumor progression and therapy response in Il-6 and Myc driven plasma cell malignancy
by: Duncan, Kaylia Mekelda
Published: (2013) -
The Proteasome Inhibitor Ixazomib Inhibits the Formation and Growth of Pulmonary and Abdominal Osteosarcoma Metastases in Mice
by: Michael A. Harris, et al.
Published: (2020-05-01) -
APEH Inhibition Affects Osteosarcoma Cell Viability via Downregulation of the Proteasome
by: Rosanna Palumbo, et al.
Published: (2016-09-01) -
Verteporfin disrupts multiple steps of autophagy and regulates p53 to sensitize osteosarcoma cells
by: Heena Saini, et al.
Published: (2021-01-01)